Ambrosia Biosciences Inc. — Form D
Ambrosia Biosciences Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-07. The offering totals $25.0M, of which $12.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-07
- Form: D
- Accession: 0002032941-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $12.5M
- Remaining: $12.5M
- Investors: 6
- Date of first sale: 2024-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520756
Issuer
- Name: Ambrosia Biosciences Inc.
- CIK: 0002032941
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1941 PEARL STREET, BOULDER, CO, 80302
- Phone: (303) 351-5800
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David S Snitman | Director | Boulder, CO |
| Nicholas Traggis | Director | Boulder, CO |
| Nicholas Traggis | Executive Officer | Boulder, CO |
| Kyle Lefkoff | Director | Boulder, CO |
| John S Orwin | Director | Boulder, CO |
| William S Marshall | Director | San Francisco, CA |
Other filings by this issuer (1)
More